Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02261688 · ClinicalTrials.gov registry record · NA
Salt and TH-17 in Healthy Human Subjects
A NA study, sponsored by Brigham and Women's Hospital.
- Terminated
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT02261688 is a NA study that was terminated before completion, run by Brigham and Women's Hospital. The registered enrollment target is 9 participants.
The verdict
NCT02261688, a NA study, was terminated before completion, sponsored by Brigham and Women's Hospital.
- TERMINATED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
The overall goal of this study is to evaluate the association between sodium and TH17 cells in human subjects. The subjects will have levels of TH-17 and various hormones measured on low salt diet, low salt diet with intravenous normal saline, and high salt diet.
Interventions
- DIETARY_SUPPLEMENT Liberal salt diet
- DIETARY_SUPPLEMENT Low salt diet
- DIETARY_SUPPLEMENT Low salt diet + IV normal saline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2014-03 |
| Est. Completion | 2019-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02261688
The ClinicalTrials.gov registry entry for NCT02261688 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Liberal salt diet is the first listed.
NCT02261688 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02261688 about?
NCT02261688 is a clinical study titled "Salt and TH-17 in Healthy Human Subjects". The overall goal of this study is to evaluate the association between sodium and TH17 cells in human subjects. The subjects will have levels of TH-17 and various hormones measured on low salt diet, low salt diet with intravenous normal saline, and high salt diet.
What is the current status of trial NCT02261688?
This trial is currently terminated. It is a NA study. The enrollment target is 9 participants. The study started on 2014-03. Estimated completion is 2019-08.
What interventions are being tested in trial NCT02261688?
The interventions under investigation include: Liberal salt diet (DIETARY_SUPPLEMENT), Low salt diet (DIETARY_SUPPLEMENT), Low salt diet + IV normal saline (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02261688?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.